Monte Rosa Therapeutics Presents Preclinical Data at the 36TH Eortc-Nci-Aacr Symposium on the Potential of Its Cyclin E1-Directed Molecular Glue Degraders for the Treatment of Ccne1-Amplified Solid Tumors

THOMSON REUTERS
23 Oct 2024

Monte Rosa Therapeutics Presents Preclinical Data at the 36TH Eortc-Nci-Aacr Symposium on the Potential of Its Cyclin E1-Directed Molecular Glue Degraders for the Treatment of Ccne1-Amplified Solid Tumors

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10